Human Phenotype Ontology 
Grandparent Node:
expand
Hematological neoplasm (HP:0004377)help
Parent Node:
expand
Lymphoma (HP:0002665)help
..Starting node
..expand
Non-Hodgkin lymphoma (HP:0012539)help
Term ID: 12539
Name: Non-Hodgkin lymphoma
Synonym:
Definition: A type of lymphoma characterized microscopically by the absence of multinucleated Reed-Sternberg cells.
Comments:
Reference: HP:0012539
Genes and Diseases:
 
       Child Nodes:
........expandT-cell lymphoma (HP:0012190) help
................... HP:0005517 T-cell lymphoma/leukemia
................... HP:0012192 Cutaneous T-cell lymphoma
................... HP:0012193 Anaplastic large-cell lymphoma
........expandB-cell lymphoma (HP:0012191) help
........expandPrimary central nervous system lymphoma (HP:0030069) help
........expandBurkitt lymphoma (HP:0030080) help

 Sister Nodes: 
..expandGastric lymphoma (HP:0045038) help
..expandHodgkin lymphoma (HP:0012189) help
..expandPulmonary lymphoma (HP:0011953) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0012539HP:0012539Non-Hodgkin lymphoma0ADA CL E G H100186OMIM:102700Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency75
HP:0012539HP:0012539Non-Hodgkin lymphoma0ATM CL E G H472795OMIM:208900ATAXIA-TELANGIECTASIA.3267
HP:0012539HP:0012539Non-Hodgkin lymphoma0ATM CL E G H472795ORPHA:52416Mantle cell lymphoma3267
HP:0012539HP:0012539Non-Hodgkin lymphoma0BCL10 CL E G H8915989ORPHA:52417MALT lymphoma18
HP:0012539HP:0012539Non-Hodgkin lymphoma0BIRC3 CL E G H330591ORPHA:52417MALT lymphoma
HP:0012539HP:0012539Non-Hodgkin lymphoma0CASP10 CL E G H8431500ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040283 - Occasional87
HP:0012539HP:0012539Non-Hodgkin lymphoma0CCND1 CL E G H5951582ORPHA:52416Mantle cell lymphoma1
HP:0012539HP:0012539Non-Hodgkin lymphoma0CD28 CL E G H9401653ORPHA:2584Classic mycosis fungoides
HP:0012539HP:0012539Non-Hodgkin lymphoma0CD28 CL E G H9401653ORPHA:3162Sézary syndrome
HP:0012539HP:0012539Non-Hodgkin lymphoma0CDKN2A CL E G H10291787ORPHA:524Li-Fraumeni syndromeHP:0040284 - Very rare289
HP:0012539HP:0012539Non-Hodgkin lymphoma0CHEK2 CL E G H1120016627ORPHA:524Li-Fraumeni syndromeHP:0040284 - Very rare833
HP:0012539HP:0012539Non-Hodgkin lymphoma0CTLA4 CL E G H14932505ORPHA:2584Classic mycosis fungoides10
HP:0012539HP:0012539Non-Hodgkin lymphoma0CTLA4 CL E G H14932505ORPHA:3162Sézary syndrome10
HP:0012539HP:0012539Non-Hodgkin lymphoma0FAS CL E G H35511920ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040283 - Occasional59
HP:0012539HP:0012539Non-Hodgkin lymphoma0FASLG CL E G H35611936ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040283 - Occasional37
HP:0012539HP:0012539Non-Hodgkin lymphoma0FCHO1 CL E G H2314929002OMIM:619164IMMUNODEFICIENCY 76; IMD76
HP:0012539HP:0012539Non-Hodgkin lymphoma0FOXP1 CL E G H270863823ORPHA:52417MALT lymphoma184
HP:0012539HP:0012539Non-Hodgkin lymphoma0IGH CL E G H34925477ORPHA:52417MALT lymphoma7
HP:0012539HP:0012539Non-Hodgkin lymphoma0IGH CL E G H34925477ORPHA:52416Mantle cell lymphoma7
HP:0012539HP:0012539Non-Hodgkin lymphoma0IKZF3 CL E G H2280613178OMIM:619437IMMUNODEFICIENCY 84; IMD84
HP:0012539HP:0012539Non-Hodgkin lymphoma0ITK CL E G H37026171OMIM:613011LYMPHOPROLIFERATIVE SYNDROME 1; LPFS151
HP:0012539HP:0012539Non-Hodgkin lymphoma0MAGT1 CL E G H8406128880OMIM:300853IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA; XMEN17
HP:0012539HP:0012539Non-Hodgkin lymphoma0MALT1 CL E G H108926819ORPHA:52417MALT lymphoma6
HP:0012539HP:0012539Non-Hodgkin lymphoma0MDM2 CL E G H41936973ORPHA:524Li-Fraumeni syndromeHP:0040284 - Very rare1
HP:0012539HP:0012539Non-Hodgkin lymphoma0MLH1 CL E G H42927127OMIM:276300Mismatch repair cancer syndrome 11819
HP:0012539HP:0012539Non-Hodgkin lymphoma0MSH6 CL E G H29567329OMIM:619097MISMATCH REPAIR CANCER SYNDROME 3; MMRCS32232
HP:0012539HP:0012539Non-Hodgkin lymphoma0MYC CL E G H46097553OMIM:113970Burkitt lymphoma11
HP:0012539HP:0012539Non-Hodgkin lymphoma0NBN CL E G H46837652ORPHA:647Nijmegen breakage syndrome706
HP:0012539HP:0012539Non-Hodgkin lymphoma0NTHL1 CL E G H49138028ORPHA:454840NTHL1-related attenuated familial adenomatous polyposisHP:0040283 - Occasional2
HP:0012539HP:0012539Non-Hodgkin lymphoma0PIK3R1 CL E G H52958979OMIM:616005Immunodeficiency 3643
HP:0012539HP:0012539Non-Hodgkin lymphoma0PMS2 CL E G H53959122OMIM:619101MISMATCH REPAIR CANCER SYNDROME 4; MMRCS41121
HP:0012539HP:0012539Non-Hodgkin lymphoma0POLE CL E G H54269177OMIM:618336Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency1129
HP:0012539HP:0012539Non-Hodgkin lymphoma0PRKCD CL E G H55809399ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040283 - Occasional10
HP:0012539HP:0012539Non-Hodgkin lymphoma0PTPRC CL E G H57889666OMIM:61992425
HP:0012539HP:0012539Non-Hodgkin lymphoma0RASGRP1 CL E G H101259878ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040283 - Occasional
HP:0012539HP:0012539Non-Hodgkin lymphoma0RASGRP1 CL E G H101259878OMIM:618534IMMUNODEFICIENCY 64; IMD64
HP:0012539HP:0012539Non-Hodgkin lymphoma0RHOH CL E G H399686OMIM:618307Epidermodysplasia verruciformis, susceptibility to, 4
HP:0012539HP:0012539Non-Hodgkin lymphoma0SH2D1A CL E G H406810820OMIM:308240Lymphoproliferative syndrome, X-linked, 137
HP:0012539HP:0012539Non-Hodgkin lymphoma0SMARCAL1 CL E G H5048511102ORPHA:1830Schimke immuno-osseous dysplasiaHP:0040284 - Very rare74
HP:0012539HP:0012539Non-Hodgkin lymphoma0SYK CL E G H685011491OMIM:619381IMMUNODEFICIENCY 82 WITH SYSTEMIC INFLAMMATION; IMD821
HP:0012539HP:0012539Non-Hodgkin lymphoma0TNFRSF1B CL E G H713311917ORPHA:2584Classic mycosis fungoides
HP:0012539HP:0012539Non-Hodgkin lymphoma0TNFRSF1B CL E G H713311917ORPHA:3162Sézary syndrome
HP:0012539HP:0012539Non-Hodgkin lymphoma0TP53 CL E G H715711998ORPHA:524Li-Fraumeni syndromeHP:0040284 - Very rare911
HP:0012539HP:0012539Non-Hodgkin lymphoma0TTC7A CL E G H5721719750OMIM:243150Gastrointestinal defects and immunodeficiency syndrome26
HP:0012539HP:0012539Non-Hodgkin lymphoma0XIAP CL E G H331592OMIM:308240Lymphoproliferative syndrome, X-linked, 181
HP:0012539HP:0030069Primary central nervous system lymphoma1 CL E G H
HP:0012539HP:0012191B-cell lymphoma1ADA CL E G H100186OMIM:102700Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency.75
HP:0012539HP:0012191B-cell lymphoma1ATM CL E G H472795ORPHA:52416Mantle cell lymphomaHP:0040281 - Very frequent3267
HP:0012539HP:0012191B-cell lymphoma1BCL10 CL E G H8915989ORPHA:52417MALT lymphomaHP:0040281 - Very frequent18
HP:0012539HP:0012191B-cell lymphoma1BIRC3 CL E G H330591ORPHA:52417MALT lymphomaHP:0040281 - Very frequent
HP:0012539HP:0012191B-cell lymphoma1CASP10 CL E G H8431500ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040283 - Occasional87
HP:0012539HP:0012190T-cell lymphoma1CASP10 CL E G H8431500ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040283 - Occasional87
HP:0012539HP:0030080Burkitt lymphoma1CASP10 CL E G H8431500ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040283 - Occasional87
HP:0012539HP:0012191B-cell lymphoma1CCND1 CL E G H5951582ORPHA:52416Mantle cell lymphomaHP:0040281 - Very frequent1
HP:0012539HP:0012190T-cell lymphoma1CD28 CL E G H9401653ORPHA:2584Classic mycosis fungoides
HP:0012539HP:0012190T-cell lymphoma1CD28 CL E G H9401653ORPHA:3162Sézary syndrome
HP:0012539HP:0012190T-cell lymphoma1CTLA4 CL E G H14932505ORPHA:2584Classic mycosis fungoides10
HP:0012539HP:0012190T-cell lymphoma1CTLA4 CL E G H14932505ORPHA:3162Sézary syndrome10
HP:0012539HP:0012191B-cell lymphoma1FAS CL E G H35511920ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040283 - Occasional59
HP:0012539HP:0030080Burkitt lymphoma1FAS CL E G H35511920ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040283 - Occasional59
HP:0012539HP:0012190T-cell lymphoma1FAS CL E G H35511920ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040283 - Occasional59
HP:0012539HP:0012191B-cell lymphoma1FASLG CL E G H35611936ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040283 - Occasional37
HP:0012539HP:0012190T-cell lymphoma1FASLG CL E G H35611936ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040283 - Occasional37
HP:0012539HP:0030080Burkitt lymphoma1FASLG CL E G H35611936ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040283 - Occasional37
HP:0012539HP:0012191B-cell lymphoma1FCHO1 CL E G H2314929002OMIM:619164IMMUNODEFICIENCY 76; IMD76
HP:0012539HP:0012191B-cell lymphoma1FOXP1 CL E G H270863823ORPHA:52417MALT lymphomaHP:0040281 - Very frequent184
HP:0012539HP:0012191B-cell lymphoma1IGH CL E G H34925477ORPHA:52417MALT lymphomaHP:0040281 - Very frequent7
HP:0012539HP:0012191B-cell lymphoma1IGH CL E G H34925477ORPHA:52416Mantle cell lymphomaHP:0040281 - Very frequent7
HP:0012539HP:0012191B-cell lymphoma1IKZF3 CL E G H2280613178OMIM:619437IMMUNODEFICIENCY 84; IMD84
HP:0012539HP:0012191B-cell lymphoma1ITK CL E G H37026171OMIM:613011LYMPHOPROLIFERATIVE SYNDROME 1; LPFS151
HP:0012539HP:0012191B-cell lymphoma1MAGT1 CL E G H8406128880OMIM:300853IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA; XMEN17
HP:0012539HP:0012191B-cell lymphoma1MALT1 CL E G H108926819ORPHA:52417MALT lymphomaHP:0040281 - Very frequent6
HP:0012539HP:0012190T-cell lymphoma1MLH1 CL E G H42927127OMIM:276300Mismatch repair cancer syndrome 11819
HP:0012539HP:0012190T-cell lymphoma1MSH6 CL E G H29567329OMIM:619097MISMATCH REPAIR CANCER SYNDROME 3; MMRCS32232
HP:0012539HP:0030080Burkitt lymphoma1MYC CL E G H46097553OMIM:113970Burkitt lymphoma.11
HP:0012539HP:0012190T-cell lymphoma1NBN CL E G H46837652ORPHA:647Nijmegen breakage syndromeHP:0040283 - Occasional706
HP:0012539HP:0012191B-cell lymphoma1NBN CL E G H46837652ORPHA:647Nijmegen breakage syndromeHP:0040283 - Occasional706
HP:0012539HP:0012191B-cell lymphoma1PIK3R1 CL E G H52958979OMIM:616005Immunodeficiency 36HP:0040284 - Very rare43
HP:0012539HP:0012190T-cell lymphoma1POLE CL E G H54269177OMIM:618336Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiencyHP:0040284 - Very rare1129
HP:0012539HP:0012190T-cell lymphoma1PRKCD CL E G H55809399ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040283 - Occasional10
HP:0012539HP:0030080Burkitt lymphoma1PRKCD CL E G H55809399ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040283 - Occasional10
HP:0012539HP:0012191B-cell lymphoma1PRKCD CL E G H55809399ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040283 - Occasional10
HP:0012539HP:0012191B-cell lymphoma1PTPRC CL E G H57889666OMIM:61992425
HP:0012539HP:0030080Burkitt lymphoma1RASGRP1 CL E G H101259878ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040283 - Occasional
HP:0012539HP:0012191B-cell lymphoma1RASGRP1 CL E G H101259878ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040283 - Occasional
HP:0012539HP:0012190T-cell lymphoma1RASGRP1 CL E G H101259878ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040283 - Occasional
HP:0012539HP:0012191B-cell lymphoma1RASGRP1 CL E G H101259878OMIM:618534IMMUNODEFICIENCY 64; IMD64
HP:0012539HP:0030080Burkitt lymphoma1RHOH CL E G H399686OMIM:618307Epidermodysplasia verruciformis, susceptibility to, 4.
HP:0012539HP:0030080Burkitt lymphoma1SH2D1A CL E G H406810820OMIM:308240Lymphoproliferative syndrome, X-linked, 137
HP:0012539HP:0012191B-cell lymphoma1SYK CL E G H685011491OMIM:619381IMMUNODEFICIENCY 82 WITH SYSTEMIC INFLAMMATION; IMD821
HP:0012539HP:0012190T-cell lymphoma1TNFRSF1B CL E G H713311917ORPHA:2584Classic mycosis fungoides
HP:0012539HP:0012190T-cell lymphoma1TNFRSF1B CL E G H713311917ORPHA:3162Sézary syndrome
HP:0012539HP:0012190T-cell lymphoma1TTC7A CL E G H5721719750OMIM:243150Gastrointestinal defects and immunodeficiency syndrome26
HP:0012539HP:0030080Burkitt lymphoma1XIAP CL E G H331592OMIM:308240Lymphoproliferative syndrome, X-linked, 181
HP:0012539HP:0012193Anaplastic large-cell lymphoma2 CL E G H
HP:0012539HP:0005517T-cell lymphoma/leukemia2 CL E G H
HP:0012539HP:0034403Subcutaneous panniculitis-like T-cell lymphoma2 CL E G H
HP:0012539HP:0033125Follicular lymphoma2 CL E G H
HP:0012539HP:0012192Cutaneous T-cell lymphoma2CD28 CL E G H9401653ORPHA:2584Classic mycosis fungoidesHP:0040282 - Frequent
HP:0012539HP:0012192Cutaneous T-cell lymphoma2CD28 CL E G H9401653ORPHA:3162Sézary syndromeHP:0040281 - Very frequent
HP:0012539HP:0012192Cutaneous T-cell lymphoma2CTLA4 CL E G H14932505ORPHA:2584Classic mycosis fungoidesHP:0040282 - Frequent10
HP:0012539HP:0012192Cutaneous T-cell lymphoma2CTLA4 CL E G H14932505ORPHA:3162Sézary syndromeHP:0040281 - Very frequent10
HP:0012539HP:0012192Cutaneous T-cell lymphoma2TNFRSF1B CL E G H713311917ORPHA:2584Classic mycosis fungoidesHP:0040282 - Frequent
HP:0012539HP:0012192Cutaneous T-cell lymphoma2TNFRSF1B CL E G H713311917ORPHA:3162Sézary syndromeHP:0040281 - Very frequent


Genes (39) :ADA ATM BCL10 BIRC3 CASP10 CCND1 CD28 CDKN2A CHEK2 CTLA4 FAS FASLG FCHO1 FOXP1 IGH IKZF3 ITK MAGT1 MALT1 MDM2 MLH1 MSH6 MYC NBN NTHL1 PIK3R1 PMS2 POLE PRKCD PTPRC RASGRP1 RHOH SH2D1A SMARCAL1 SYK TNFRSF1B TP53 TTC7A XIAP

Diseases (27) :OMIM:102700 OMIM:208900 ORPHA:52416 ORPHA:52417 ORPHA:3261 ORPHA:2584 ORPHA:3162 ORPHA:524 OMIM:619164 OMIM:619437 OMIM:613011 OMIM:300853 OMIM:276300 OMIM:619097 OMIM:113970 ORPHA:647 ORPHA:454840 OMIM:616005 OMIM:619101 OMIM:618336 OMIM:619924 OMIM:618534 OMIM:618307 OMIM:308240 ORPHA:1830 OMIM:619381 OMIM:243150
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.